Empathy & psychosis

Completed

• Conditions: 10039628; psychosis

• Registration Number: NL-OMON44395
• Lead Sponsor: Rijksuniversiteit Groningen

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Last Update Posted: 23 April 2024

Recruitment & Eligibility

• Status: Completed
• Sex: Not specified
• Target Recruitment: 90

Inclusion Criteria

Patients with schizophrenia:;- Diagnosis of schizophrenia or schizoaffective disorder, according to DSM-IV-TR criteria;
- Being able to give informed consent;
- 18 years or older;
- No change in medication in the past thirty days;
- Low metacognition (group 1) and high metacognition (group 2). ;Patients in UHR group:;- At risk of psychosis determined by genetic risk or the CAARMS;
- Being able to give informed consent;
- No change in medication in the past thirty days.

Exclusion Criteria

All participants:;- Florid psychosis;
- Comorbid neurological disorder;
- Substance dependence (not substance abuse);
- IQ < 70.

Study & Design

• Study Type: Observational non invasive
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
<p>Empathy as measured with the Empathic Accuracy Test, Faux Pas Test,<br /><br>Interpersonal Reactivity Index, Questionnaire of Cognitive and Affective<br /><br>Empathy en the Metacognition Assessment Scale. </p><br>

Secondary Outcome Measures

Name	Time	Method
<p>Social functioning (Time Use) Insight (Beck Cognitive Insight Scale),<br /><br>Depression (Quick Inventory of Depressve Symptomalogy), Stigma (Internalized<br /><br>Stigma of Mental Illness Scale) Quality of Life (Manchester Short Assessment of<br /><br>Quality of Life).</p><br>